Randomized, double-blind, placebo-controlled trial of Niaspan [niacin] in patients with overt diabetic nephropathy and moderate renal impairment

Trial Profile

Randomized, double-blind, placebo-controlled trial of Niaspan [niacin] in patients with overt diabetic nephropathy and moderate renal impairment

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Niacin (Primary)
  • Indications Hyperlipidaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Jul 2007 The expected completion date for this trial is now 1 Apr 2007.
    • 01 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top